Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer

Title
Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
Authors
Keywords
-
Journal
Translational Cancer Research
Volume 9, Issue 3, Pages 1319-1321
Publisher
AME Publishing Company
Online
2020-03-30
DOI
10.21037/tcr.2020.01.16

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now